Picture of Coloplast A/S logo

COLO B Coloplast A/S Cashflow Statement

0.000.00%
dk flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Coloplast A/S, fiscal year end - September 30th, DKK millions except per share, conversion factor applied.

2019
September 30th
2020
September 30th
2021
September 30th
2022
September 30th
2023
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line5,1565,8546,1556,4396,771
Depreciation
Amortisation
Non-Cash Items213-135-3156-220
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1,663-1,811-1,624-2,328-3,394
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities4,3574,7595,2925,0974,226
Capital Expenditures-690-931-1,966-1,135-1,241
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items9930-45-10,624-7,716
Acquisition of Business
Sale of Fixed Assets
Change in Net Investments
Purchase of Investments
Cash from Investing Activities-591-901-2,011-11,759-8,957
Financing Cash Flow Items521
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-3,714-3,857-3,1766,5915,265
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash59-33125-34497